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The breakdown of triglycerides, or lipolysis, is a tightly controlled
process that regulates fat mobilization in accord with an animal’s
energy needs. It is well established that lipolysis is stimulated by hor-
mones that signal energy demand and is suppressed by the antilipo-
lytic hormone insulin.However,much still remains tobe learnedabout
regulation of lipolysis by intracellular signaling pathways in adipo-
cytes. Here we show that galectin-12, a member of a β-galactoside–
binding lectin family preferentially expressed by adipocytes, func-
tions as an intrinsic negative regulator of lipolysis. Galectin-12 is
primarily localized on lipid droplets and regulates lipolytic protein
kinase A signaling by acting upstream of phosphodiesterase activ-
ity to control cAMP levels. Ablation of galectin-12 in mice results in
increased adipocyte mitochondrial respiration, reduced adiposity,
and ameliorated insulin resistance/glucose intolerance. This study
identiﬁes unique properties of this intracellular galectin that is lo-
calized to an organelle and performs a critical function in lipid me-
tabolism. These ﬁndings add to the signiﬁcant functions exhibited
by intracellular galectins, and have important therapeutic implica-
tions for human metabolic disorders.
obesity | energy metabolism | diabetes
The galectin family of animal lectins encompasses 15 membersinmammals with conserved carbohydrate-recognition domains
(CRD) that bind β-galactoside (1). Unlike most other animal
lectins that are synthesized on endoplasmic reticulum-bound
ribosomes and delivered to the cell surface or secreted via the
endoplasmic reticulum/Golgi pathway, galectins possess charac-
teristics of intracellular proteins and are synthesized on free
ribosomes (2). However, galectins can also be detected on the cell
surface and extracellular space. Previous research describe galec-
tins as possessing both intracellular and extracellular functions in
a variety of cellular processes, including cell–cell and cell–extra-
cellular matrix interactions, intracellular vesicle trafﬁcking, cell
growth, apoptosis, and cell activation that impact innate and
adaptive immunity, as well as cancer initiation, progression, and
metastasis (reviewed in refs. 2–7).
We cloned cDNA coding for a human two-CRD galectin,
galectin-12 (8). Themouse gene was subsequently cloned byHotta
et al. (9), who also showed by Northern blotting its preferential
expression in adipose tissue. Using the serial analysis of gene ex-
pression strategy, the gene was later found to be one of the few
genes that are speciﬁcally expressed in mouse adipose tissue (10).
At times of energy surplus, fatty acids are converted into trigly-
cerides in these cells and stored in specialized lipid-droplet
organelles (11). When needed, triglyceride can be hydrolyzed into
fatty acids and glycerol in a tightly controlled process known as
lipolysis (12). There is a delicate balance between triglyceride
synthesis and lipolysis in healthy animals. Disturbance of such
a balance can result in lipodystrophy or obesity. It is well estab-
lished that both obesity and lipodystrophy can result in insulin
resistance, type 2 diabetes, and an increased risk for cardiovascular
disease (13).
Lipolysis is regulated by opposing mechanisms, largely via
modulation of intracellular concentrations of cAMP. In the
present studies, we have investigated the localization of galectin-
12 and the role of this protein in adipocytes and adiposity by
generating and studying galectin-12–deﬁcient (Lgals12−/−) mice.
Here we demonstrate that galectin-12 is a lipid-droplet protein
that regulates lipolytic PKA signaling. Galectin-12 deﬁciency in
mice results in enhanced lipolysis, reduced adiposity, and ame-
liorated insulin resistance.
Results
Galectin-12 Ablation Reduces Adiposity Associated with Decreased
Adipocyte Triglyceride Content. It has been previously reported that
galectin-12 is preferentially expressed in adipose tissue and that its
expression is regulated by hormones and cytokines that regulate
insulin sensitivity (9, 14), suggesting its involvement in energy
homeostasis. To study the role of galectin-12 in energymetabolism
in vivo, we generated galectin-12–deﬁcient (Lgals12−/−) mice (Fig.
S1) and examined their adipose tissue phenotype. We found that
Lgals12−/− animals had substantially reduced visceral (epididymal)
and subcutaneous (inguinal) white adipose tissue, despite normal
body weights (Fig. 1A). Reduced adiposity of Lgals12−/−mice was
also supported by body composition analysis, which showed
a ∼40% reduction in whole-body lipid content (Table S1). The
strong positive correlation between body weights and weights of
fat depots seen in Lgals12+/+ mice was not observed in Lgals12−/−
mice (Fig. 1B). Epididymal fat depots of Lgals12−/− mice con-
tained less triglyceride compared with Lgals12+/+ mice, but the
number of adipocytes was not signiﬁcantly altered (Fig. 1C).
Consistent with this ﬁnding, the adipocytes of Lgals12−/− mice
were smaller in size (Fig. 1D). These results indicate that the de-
crease in size of fat depots in Lgals12−/− mice is because of a re-
duction of triglyceride content and not tissue cellularity.
An early report suggested that galectin-12 is involved in adi-
pogenesis in vitro (15). However, we did not observe major
alterations in the expression of several adipose genes examined in
Lgals12−/− mice, suggesting that adipose tissue development in
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these mice are largely normal (Fig. S2 and Table S2). Neverthe-
less, the levels of leptin expression in adipose tissue were signi-
ﬁcantly lower in these mice. This is likely the result of reduced
adiposity because leptin expression is regulated by adiposity (16).
Galectin-12 Is Localized to Adipocyte Lipid Droplets. We generated
mouse anti-galectin-12 antibodies and used them for cellular lo-
calization of galectin-12. The antibodies recognize a single protein
band on Western blotting of protein extracts from Lgals12+/+
adipose tissue but not Lgals12−/− adipose tissue (Fig. S1C, Lower),
establishing its speciﬁcity. Unlike adipokines, such as adiponectin,
galectin-12 is not secreted in a signiﬁcant amount under normal
conditions (Fig. 2A). Using a well-established cellular fraction-
ation method for 3T3-L1 adipocytes (17), we found that galectin-
12 was detectable in the low-density microsomal fraction, but the
vast majority copuriﬁed with lipid droplets (Fig. 2B), as did peril-
ipin A, a known lipid-droplet protein (18). This ﬁnding was further
conﬁrmed by costaining with Bodipy 493/503, a ﬂuorescent dye
speciﬁc for neutral lipids in lipid droplets (Fig. 2C, Upper). Cos-
taining with anti-perilipin A antibody revealed that although per-
ilipin A was found on both small and large lipid droplets, galectin-
12 was mainly localized on large droplets (Fig. 2C, Lower).
Galectin-12 protein could be detected 4 d after induction of
3T3-L1 adipocyte differentiation. At this early stage, most lipid
droplets were small and only a few larger droplets were coatedwith
galectin-12. The levels of galectin-12 plateaued around 1 wk into
differentiation. At this mature stage,most lipid droplets were large
and positive for galectin-12, but some remained small and negative
for this protein (Fig. 2 D and E).
To test whether galectin-12 association with lipid droplets is
glycan-dependent, we also puriﬁed lipid droplets in the presence
of lactose. Lactose at a concentration of 25 mM, which completely
inhibited the binding of galectin-12 to fetuin-agarose (Fig. S3A),
did not affect galectin-12 association with lipid droplets (Fig.
S3B), suggesting that the association is not likely to be mediated
by glycans.
Galectin-12 Deﬁciency Enhances Lipolysis. The lipid-droplet protein
perilipin A plays an important role in lipolysis. Similarly, we found
that lipolysis in Lgals12−/− adipocytes was approximately twofold
higher compared with equal numbers of Lgals12+/+ cells, both
under basal conditions (Fig. 3A) and when stimulated with the
β-adrenergic receptor agonist isoproterenol (Fig. 3B). Even
greater differences were observed when equal volumes of packed
cells were compared (Fig. S4). We also used RNA interference to
further conﬁrm the effects of galectin-12 on lipolysis. Transfection
of 3T3-L1 adipocytes with galectin-12 siRNAs signiﬁcantly sup-
pressed galectin-12 expression and enhanced isoproterenol-stim-
ulated lipolysis (Fig. 3C). Negative control of lipolysis by galectin-
12 is consistent with its speciﬁc localization to large lipid droplets
in mature adipocytes (Fig. 2C), as centrally located, large lipid
droplets are known to be less sensitive to lipolytic stimulation than
those small, peripheral droplets (19).
Despite increased lipolysis, serum glycerol and fatty acid levels
were not increased in Lgals12−/− mice (Table S3). Lipid contents
of liver andmuscle were also comparable betweenLgals12+/+ and
Lgals12−/−mice (Fig. 4A). There were no signiﬁcant differences in
food intake (Fig. 4B) or ambulatory activity (Fig. 4C) between the
two genotypes, yet we observed increased oxygen consumption by
Lgals12−/− animals indicative of increased energy expenditure
(Fig. 4D). In a similar fashion to white adipocytes deﬁcient in the
lipid-droplet protein FSP27 (fat-speciﬁc protein of 27 kDa) (20,
21) or the critical macroautophage gene Atg7 (autophagy-related
Fig. 1. Galectin-12 deﬁciency reduces adiposity in mice.
(A) Comparison of weights of visceral (epididymal) and
subcutaneous (inguinal) white adipose tissue in Lgals12+/+
and Lgals12−/− mice (+/+, n = 13; −/−, n = 18), as well as
interscapular brown adipose tissue (BAT) and body
weight. (B) Linear regression analyses show that body
weight and fat depot weight are highly correlated in
Lgals12+/+ mice (epididymal, R2 = 0.586, P = 0.002; in-
guinal, R2 = 0.887, P < 0.0001), but not in Lgals12−/− mice
(epididymal, R2 < 0.00001, P = 0.992; inguinal, R2 = 0.015,
P = 0.676). (C ) Triglyceride contents and adipocyte num-
bers of epidydymal fat depots from Lgals12+/+ (n = 5) and
Lgals12−/− (n = 4) mice. (D) H&E staining of parafﬁn sec-
tions of epididymal fat depots from Lgals12+/+ and
Lgals12−/− mice (representative of four experiments). Av-
erage diameters of >200 isolated adipocytes were de-
termined from their digital images with ImageJ software using 100-μm Polybead polystyrene microspheres (Polysciences) as references. Results are from
22- to 24-wk-old males. Asterisks denote statistical signiﬁcance (*P < 0.05).
Fig. 2. Galectin-12 is a lipid droplet protein. (A) 3T3-L1 adipocytes were
incubated for 2 h in serum-free DMEM. Protein levels of extracellular (in
conditioned medium) and intracellular (cell-associated) galectin-12 and adi-
ponectin were determined by Western blotting using speciﬁc antibodies. (B)
Lipid droplets (LD) were puriﬁed from 3T3-L1 adipocytes by density gradient
centrifugation, and the remaining cellular components were separated by
differential centrifugation into ﬁve fractions containing plasma membrane
(PM), high-density microsomes (HDM), low-density microsomes (LDM), cyto-
sol, andmitochondria/nuclei (M/N). Levels of galectin-12, Glut-4, and perilipin
A were determined in each fraction by Western blotting with respective
speciﬁc antibodies. Each lane represents samples from an equal number of
cells. (C) Immunostaining of 3T3 adipocytes showing galectin-12 (red) and
perilipin A (green, Lower) on lipid droplets (green, Upper). (D) 3T3-L1 cells
were incubated in the presence (MDI+) or absence (MDI−) of the adipogenic
hormone mixture to induce adipocyte differentiation. At indicated time
points, cells were extracted for analysis of galectin-12 expression by Western
blotting. (E) 3T3-L1 cells at various periods during differentiation were
stained for galectin-12 (red), lipid droplets (green), and the nuclei (blue). Data
are representative of three experiments with similar results.
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7) (22), Lgals12−/− white adipocytes exhibited increased oxygen
consumption (Fig. 4E). Induction of lipolysis with isoproterenol
resulted in greater stimulation of oxygen consumption in
Lgals12−/− adipocytes compared with Lgals12+/+ cells (Fig. 4F).
The results indicate that enhanced mitochondrial respiration in
white adipocytes contributes to increased energy expenditure in
Lgals12−/− mice.
Lgals12−/− Adipocytes Show Elevated PKA Phosphorylation of
Hormone-Sensitive Lipase and Association of Adipocyte Triglyceride
Lipase with Lipid Droplets. PKA phosphorylation is a critical event
for the activation and recruitment of hormone-sensitive lipase
(HSL) to lipid droplets (23, 24), where it operates in concert with
adipocyte triglyceride lipase (ATGL) to hydrolyze stored lipids
(25–27). We treated primary adipocytes from Lgals12+/+ and
Lgals12−/−mice with isoproterenol, separated the cytosolic and fat
cake proteins, and then analyzed them by Western blotting. Total
HSL tended to be higher in Lgals12−/− adipocytes (Fig. 5A), which
could be partially responsible for the increased lipolysis. Stimula-
tion with isoproterenol resulted in approximately twofold higher
phospho-HSL levels in the fat cake of Lgals−/− adipocytes com-
pared withLgals12+/+ adipocytes (Fig. 5A andB). Consistent with
enhanced translocation of PKA-phosphorylated HSL, the total
HSL levels in lipid droplets ofLgals−/− adipocytes were also higher
than those in lipid droplets of Lgals12+/+ adipocytes after iso-
proterenol stimulation (Fig. 5 A and B).
Enhanced PKA phosphorylation of HSL was also conﬁrmed by
immunoﬂuorescence staining of mouse primary embryonic ﬁ-
broblast (MEF)-derived adipocytes from Lgals12+/+ and Lgals−/−
mice (Fig. 5C). We also observed more ATGL associated with
lipid droplets in Lgals12−/− adipocytes compared with Lgals12+/+
counterparts, with or without isoproterenol stimulation (Fig. 5 A
and D). There were no signiﬁcant differences in total ATGL or
perilipin levels between adipocytes of the two genotypes (Fig. 5A).
These results suggest that increased PKA phosphorylation/acti-
vation of adipocyte lipases and their recruitment to lipid droplets
account for enhanced lipolysis in Lgals12−/− adipocytes.
Defective PDE Activity Contributes to Enhanced cAMP Levels and
Lipolysis in Lgals12−/− Adipocytes. PKA activity is dynamically
regulated by the second messenger cAMP. We compared the in-
tracellular cAMP levels of Lgals12+/+ and Lgals12−/− adipocytes
before and after stimulation with various concentrations of iso-
proterenol and found that the cAMP levels in Lgals12−/− adipo-
cytes were signiﬁcantly higher than in Lgals12+/+ adipocytes (Fig.
5E). This ﬁnding suggests that galectin-12 acts upstream of PKA
to regulate lipolysis by restricting intracellular cAMP levels.
Intracellular cAMP levels are regulated by stimulatory and in-
hibitory signaling that regulate adenylyl cyclase activity, as well as
enzymes (PDEs) that catalyze its degradation. Treatment with
isobutylmethylxanthine (IBMX), which is both a broad-spectrum
PDE inhibitor and an adenosine antagonist, greatly enhanced li-
polysis in both Lgals12+/+ and Lgals12−/− adipocytes and elimi-
nated the observed differences between the two genotypes (Fig.
5F). This result suggests that upstream stimulatory signaling
leading to adenylyl cyclase activation does not differ between
the two genotypes, and defective tonic antilipolytic mechanisms
Fig. 3. Galectin-12 deﬁciency results in elevated lipolysis in
adipocytes. (A and B) Adipocytes were isolated from epi-
didymal fat depots of Lgals12+/+ and Lgals12−/−mice (n = 3–
6) on a regular diet ad libitum. Equal numbers of cells were
incubated in the absence (A) or presence (B) of 0.1 μM of
isoproterenol. Glycerol and nonesteriﬁed fatty acid (NEFA)
released into the medium were measured at different time
points of incubation at 37 °C. (C) siRNA-mediated knock-
down was performed by electroporating 3T3-L1 adipocytes
with either control siRNA (Ctrl) or a combination of two
galectin-12–speciﬁc siRNAs (si12). Three days later, galectin-
12 levels were analyzed by Western blotting, and lipolysis
was determined by monitoring the release of fatty acids
and glycerol 1.5 h after isopreterenol stimulation. Asterisks
denote statistical signiﬁcance (*P < 0.05). Similar results
were observed in four (A and B) or three (C) experiments.
Fig. 4. Tissue lipid content, total ambulatory activity, energy expenditure,
and food intake in Lgals12+/+ and Lgals12−/− mice. (A) Lipid contents of liver
andmusclewere determined for Lgals12+/+ and Lgals12−/−malemice (n = 5 for
each genotype), by the ethanolic-KOH saponiﬁcationmethod. (B) Food intake
of Lgals12+/+ (n = 5) and Lgals12−/− (n = 6). (C and D) Total ambulatory activity
(distance of movement) and oxygen consumption rates (VO2) were de-
termined by indirect calorimetry during the dark (7:00 PM to 7:00 AM) and
light (7:00AM to 7:00 PM) periods in Lgals12+/+ and Lgals12−/−malemice (n = 5
for each genotype) on standard diet. (E and F) Basal (E) or isoproterenol-
stimulated (F) oxygen consumption of isolated epididymal white adipocytes
from Lgals12+/+ and Lgals12−/− mice (n = 5–7) measured with the BD Oxygen
Biosensor System. Oxygen consumption in E is expressed as normalized rela-
tive ﬂuorescence unit (NRFU). Results in F are the ratios of oxygen consump-
tion by adipocytes stimulated with isoproterenol to that by adipocytes under
basal conditions. All animals were studied at 22 to 26 wk of age. Asterisks
denote statistical signiﬁcance (*P < 0.05).
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(adenosine signaling or PDE activity) are responsible for en-
hanced lipolysis in Lgals12−/− adipocytes.
Incubation with adenosine deaminase (ADA), which converts
extracellular adenosine to inosine, failed to eliminate differential
lipolysis between Lgals12+/+ and Lgals−/− cells (Fig. 5F). In the
meantime, (−)-N6-(2-Phenylisopropyl)adenosine, an ADA-re-
sistant A1 adenosine receptor agonist, suppressed lipolysis in both
genotypes with similar efﬁciencies (Fig. S5A). The results suggest
that the adenosine signaling pathway does not account for differ-
ential lipolysis in Lgals12+/+ and Lgals−/− cells. Instead, defective
PDE activity is responsible for enhanced lipolysis in Lgals12−/−
adipocytes. This ﬁnding was further conﬁrmed by direct incubation
of Lgals12+/+ and Lgals12−/− adipocytes with cAMP, or its PDE-
resistant analog dibutyryl cAMP (dbcAMP), in the presence of the
cell-permeable adenylyl cyclase inhibitor, SQ 22536. Incubation
with cAMP stimulated greater lipolysis in Lgals12−/− adipocytes
than in Lgals12+/+ adipocytes, whereas incubation with the PDE-
resistant dbcAMP induced comparable lipolysis in adipocytes
of the two genotypes (Fig. 5G). Results from experiments with
inhibitors of PDE3 and PDE4 suggest that the PDEmodulated by
galectin-12 in lipolysis is distinct from these two families of phos-
phodiesterases (Fig. S5B). Consistent with our hypothesis, lipolysis
in Lgals12−/− adipocytes remained sensitive to insulin (Fig. S5C),
which suppresses lipolysis by activating PDE3B (28, 29).
Galectin-12 Deﬁciency Prevents the Development of Insulin
Resistance and Glucose Intolerance Associated with Weight Gain.
Elevated weight gain and obesity are associated with alterations in
adipose tissue functions that predispose an individual to insulin
resistance and glucose intolerance preceding the development of
type 2 diabetes (13, 30). We compared insulin resistance (Fig. 6A)
and glucose intolerance (Fig. 6B) of Lgals12+/+ and Lgals12−/−
mice, as measured by integrating blood glucose levels as a function
of time after intraperitoneal injection of insulin or glucose indicated
by area under the curve (AUC). In Lgals12+/+ mice, insulin re-
sistance and glucose intolerance strongly and positively correlated
with body weight. In contrast, no such correlations were observed in
Lgals12−/−mice (Fig. 6 A and B). Because Lgals12+/+ mice > 30 g
developed insulin resistance and glucose intolerance (Fig. 6 A and
B, Center), we used the 30-g cutoff to test whether galectin-12 ab-
lation improves these parameters, a common practice used in
similar studies (31, 32). Results presented in Fig. 6 A and B, Center
and Right, show that galectin-12 deﬁciency improved insulin sensi-
tivity and glucose tolerance in mice heavier than 30 g. In compar-
ison, perilipin deﬁciency augmented insulin resistance and glucose
intolerance in mice exceeding 30 g, possibly as a result of elevated
blood levels of fatty acids that impair insulin sensitivity (32).
ComparedwithLgals12+/+ animals, improved glucose tolerance
in mice > 30 g was achieved with lower insulin levels in Lgals12−/−
mice (Fig. 6C), consistent with increased insulin sensitivity in these
animals. Improved insulin action and glucose homeostasis in
Lgals12−/− mice could be the result of reduced adiposity in these
mice, or improved adipose tissue function compared with wild-
type mice of similar adiposity. Analyses of insulin resistance and
glucose intolerance in relation to adiposity inmice revealed similar
functional correlations between both genotypes (Fig. 6 D and E),
suggesting that galectin-12 deﬁciency enhances insulin responses
primarily as a result of reduced adiposity.
Discussion
Our work identiﬁes galectin-12 as a negative regulator of lipolysis
that is preferentially expressed in adipocytes. It is speciﬁcally lo-
calized on lipid droplets and regulates lipolytic PKA signaling.
Galectin-12 deﬁciency reduces adiposity and prevents de-
velopment of insulin resistance associated with increased body
weight. Thus, we identify a unique intracellular galectin per-
forming a critical function in lipid metabolism that is speciﬁcally
localized to an organelle.
Galectin-12 ablation altered neither the expression of major
adipose genes (Fig. S2) nor the number of adipocytes (Fig. 1C) in
adipose tissue. This ﬁnding suggests that adipogenesis is largely
normal in Lgals12−/− mice, despite previous observations that
galectin-12 expression was required for the adipocyte differentia-
tion of 3T3-L1 cells in vitro (15). The absence of an overt adipo-
Fig. 5. Galectin-12 ablation promotes PKA
phosphorylation of HSL and association of
phosphorylated HSL and ATGL with lipid
droplets as a result of elevated cAMP levels.
(A) Adipocytes from the epididymal fat
depots of Lgals12+/+ and Lgals12−/− mice
were incubated with indicated concen-
trations of isoproterenol before being sepa-
rated into cytosol and fat cake. Lipolytic
proteins in each fraction were analyzed by
Western blotting with indicated antibodies.
(B) Quantiﬁcation of lipid droplet (LD)-asso-
ciated p-HSL and HSL by densitometry of
Western blots (n = 3 for each genotype). (C)
Immunoﬂuorescence of adipocytes differen-
tiated from MEFs shows elevated levels of
phospho-HSL associated with lipid droplets in
Lgals12−/− adipocytes 15 min after treatment
with 0.1 μM isoproterenol. (D) Quantiﬁcation
of lipid droplet-associated ATGL by densi-
tometry of Western blots (n = 3 for each
genotype). (E ) Adipocytes from Lgals12+/+
(n = 3) and Lgals12−/− (n = 3) mice were in-
cubated with indicated concentrations of
isoproterenol for 5 min at 37 °C and in-
tracellular cAMP levels were determined by
ELISA. (F) Adipocytes from Lgals12+/+ and
Lgals12−/− mice (n = 3–6) were treated with
or without 0.1 mM IBMX or 1 U/mL ADA for 1
h at 37 °C and lipolysis was determined by
measuring glycerol release. (G) cAMP/dbcAMP-stimulated lipolysis in adipocytes from Lgals12+/+ and Lgals12−/− mice (n = 4). Asterisks denote statistical
signiﬁcance (*P < 0.05). Results are representative of three experiments.
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genic phenotype in vivo may be explained by genetic robustness
against null mutations in the germ line (33). Thus, absence of the
adipogenesis phenotype in Lgals12−/− mice is likely the result of
functional compensation by another adipogenic pathway.
Lgals12+/+ andLgals12−/−mice exhibited similar growth curves
when they were fed a high-fat diet for up to 12 wk (Fig. S6A).
Their body weights and fat weights were indistinguishable after 22
wk on this diet (Fig. S6B). Similarly, galectin-12 deﬁciency did not
signiﬁcantly alter adiposity in young leptin-deﬁcient (ob/ob) mice
(Fig. S6C). This result may be explained by the fact that in both
models, obesity develops mainly as a result of excessive food in-
take. Thus, synthesis of triglycerides in these animals greatly
exceeds fat mobilization (lipolysis) and this massive synthesis is
likely to marginalize the contribution of lipolysis to the devel-
opment of increased adiposity. Indeed, in the diet-induced obe-
sity model, a greater reduction of adiposity in ob/ob Lgals12−/−
mice was observed after animals were fasted to eliminate the
contributions of food/lipid intake and positive energy balance and
to simultaneously stimulate lipolysis (Fig. S6B). Similarly, galec-
tin-12 ablation reduced adiposity of ob/ob mice after aging (12
mo) (Fig. S6D), when hyperphagia lessens.
PKA signaling is characterized by spatiotemporal regulation of
signal strength and speciﬁcity (34, 35). As an example, PKA ac-
tivation can be regulated locally by compartmentalized PDE ac-
tivity that degrades cAMP (35, 36). Predominant localization of
galectin-12 in lipid droplets suggests that it could contribute to
such spatial speciﬁcity of PKA signaling to lipolytic substrates on,
or around the lipid droplet. Such localized regulation of PKA
signaling by galectin-12 is supported by our observation that in
wild-type adipocytes, lipid droplets with higher levels of galectin-
12 are associated with lower PKA-phosphorylated HSL in re-
sponse to stimulation by isoproterenol (Fig. 5C).
The mechanisms by which the perilipin family of lipid-droplet
proteins are associated with lipid droplets may be diverse. How-
ever, it appears that they all involve hydrophobic interactions (37).
Although it is presently unknown how galectin-12 is anchored to
lipid droplets, galactosyl glycans are not likely to be involved, as
the association of galectin-12 to lipid droplets was unaffected by
the presence of lactose (Fig. S3). On the other hand, there are
several hydrophobic regions in the galectin-12 molecule that may
contribute to its localization to lipid droplets (Fig. S7). Lipid
domains may also serve as a hydrophobic matrix that helps shape
galectin-12 into a functional conformation.
Our results suggest that enhanced lipolysis in Lgals12−/−mice is
associated with increased mitochondrial respiration in adipocytes
and elevated whole-body energy expenditure. Because galectin-12
was not found in the mitochondrial fraction, it is not likely that it
directly regulates mitochondrial function. Instead, enhanced li-
polysis in these cells could lead to elevated levels of intracellular
fatty acids that serve both as fuel for the mitochondria and ligands
for the peroxisome proliferator-activated receptor family of tran-
scription factors to activate genes that promote mitochondrial
biogenesis (38). In addition, fatty acids have been shown to activate
AMP-activated protein kinase (AMPK) that functions to stimulate
fatty acid oxidation (39), all of which could contribute to higher
rates of mitochondrial respiration in Lgals12−/− adipocytes.
Taken together, the results from these experiments suggest that
enhanced lipolysis in Lgals12−/−mice is associated with increased
utilization of lipolytic products as fuel for mitochondrial respira-
tion, contributing to higher whole-body energy expenditure and
lower adiposity in these mice. Such changes in energy metabolism
favor enhanced insulin action in the regulation of glucose ho-
meostasis. From a clinical viewpoint, pharmaceutical targeting of
galectin-12 may prove beneﬁcial by both reducing adiposity and
improving insulin sensitivity.
In conclusion, we have identiﬁed galectin-12, an intracellular
galectin that is preferentially expressed in adipocytes, as a po-
tential therapeutic target for obesity and associated metabolic
conditions, such as insulin resistance and glucose intolerance,
which predispose individuals to develop type 2 diabetes. The
majority of previous studies of galectins have investigated their
functions in the extracellular domain and generated a number of
interesting ﬁndings (reviewed in ref. 4). We anticipate that this
study will lead to additional investigations of the role of galectins
in the regulation of intracellular signaling that controls many
important cellular processes, including energy metabolism.
Materials and Methods
Isolation of Primary Mouse Adipocytes. Adipocytes were isolated from go-
nadal fat depots in Krebs–Ringer Hepes (KRH) buffer by collagenase digestion
Fig. 6. Galectin-12 deﬁciency reduces insulin re-
sistance and glucose intolerance associated with
weight gain. (A and B) AUC was computed from the
plot of blood glucose levels as a function of time after
intraperitoneal injection of Lgals12+/+ and Lgals12−/−
mice with insulin (A) or glucose (B). The AUC values,
which reﬂect insulin resistance (A) or glucose in-
tolerance (B), were then plotted as a function of body
weight. Note that insulin resistance and glucose in-
tolerance correlate with body weight in Lgals12+/+
mice (insulin resistance vs. body weight, R2 = 0.583, P =
0.002; glucose intolerance vs. body weight, R2 = 0.353,
P = 0.032). Such correlation was absent in Lgals12−/−
mice (insulin resistance vs. body weight, R2 < 0.001, P =
0.933; glucose intolerance vs. body weight, R2 = 0.004,
P = 0.829). (C) Changes in plasma insulin levels in mice
weighing > 30 g during the ﬁrst hour of the glucose
tolerance test. (D and E) Plots of insulin resistance and
glucose intolerance, as described in A and B, re-
spectively, as a function of adiposity. Asterisks denote
statistical signiﬁcance (*P < 0.05). Results are repre-
sentative of three to four experiments.
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and ﬂoatation (40). After the ﬁnal wash, cell density and triglyceride content
of the adipocyte suspension were determined as described (41).
Cellular Fractionation and Lipid Droplet Puriﬁcation. Differential centrifuga-
tion-based fractionation of 3T3-L1 adipocyte homogenates into fractions rich
in plasma membranes (PM), high-density microsomes (HDM), low-density
microsomes (LDM), cytosol, nuclei, and mitochondria (M/N) was performed
essentially as described (17). Lipid droplets were puriﬁed from 3T3-L1 adi-
pocytes by density gradient centrifugation (42).
Deconvolution Immunoﬂuorescence Microscopy. Mouse embryonic ﬁbroblasts
(MEFs) were isolated as described (43). Adipocyte differentiation of primary
MEFs and 3T3-L1 ﬁbroblasts was induced with an adipogenic hormone com-
bination (15). Cells were precessed for immunostaining of cellular proteins as
described (44). Lipid droplets and nuclei were stained with 1 μg/ml Bodipy 493/
503 (Invitrogen) and 1 μg/ml Hoechst 33342 (Invitrogen), respectively. Fluores-
cent signals were visualized using an Olympus B×61 ﬂuorescence microscope by
capturing z-plane images at 1-μm intervals encompassing the depth of the cell.
Flat-ﬁeld-corrected image stacks were deconvolved by the constrained iterative
method to mathematically remove out-of-focus light from the ﬂuorescent
image set using SlideBook 4.1 software (Intelligent Imaging Innovations).
Lipolysis Assay. We monitored lipolysis in adipocytes isolated from random-
fed Lgals12+/+ and Lgals12−/− mice on regular diet, by measuring fatty acid
and glycerol release, as described (40), with minor modiﬁcations. Brieﬂy,
2.5 × 105 cells were incubated in 0.3 ml KRH/3% FAA-free BSA (for basal
lipolysis), or KRH/3% FAA-free BSA containing indicated concentrations of
lipolysis stimulators or inhibitors (Sigma) for 0-2 h at 37 °C with shaking at
150 rpm on an Innova 4335 incubator shaker (New Brunswick Scientiﬁc Co.,
Inc., Edison, NJ). At the end of the incubation, glycerol and NEFA released
into the infranatant was determined with the Free Glycerol Reagent (Sigma)
and the Nonesteriﬁed Fatty Acids Kit (Catachem), respectively.
Generation of Lgals12−/− mice, RNA interference in 3T3-L1 adipocytes, oxy-
gen consumption of adipocytes, assay for isoproterenol-induced protein phos-
phorylation and translocation in adipocytes, intraperitoneal insulin sensitivity
and glucose tolerance assays, generation of galectin-12 antibodies, deter-
mination of food intake, energy expenditure, and tissue triglyceride contents,
and additional details are described in detail in SI Materials and Methods.
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